Keywords: mixed, fortunes, insmed, products, reported, preliminary, data

Mixed fortunes for Insmed products

Article | 27 November 2000

Print This

Insmed has reported preliminary data from a Phase II trial which showedthat its insulin-like growth factor-1 product SomatoKine, delivered by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in